Second, we validated the expression of key TFs in an MPTP/MPP+ model of PD neuroinflammation, but additional in vivo experiments are needed to understand how NFATc2 regulates ISG expression and disease progression. This evidence concerns the gene NFATC2 and Parkinson disease.